The Lancet Microbe

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.

Ramasamy MN, Kelly EJ, Seegobin S, ..., Green JA, AZD2816 Study Group

The Lancet Microbe - (-) - [2023-09-29; online 2023-09-29]

Category: Vaccines Type: Journal article

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose.

Bladh O, Marking U, Havervall S, ..., Klingström J, Thålin C

The Lancet Microbe 4 (7) e488 [2023-07-00; online 2023-04-20]

Category: Biochemistry Category: Health Funder: Hjärt-Lungfonden Funder: KAW/SciLifeLab Funder: VR Type: Journal article

Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study

Fischer N, Dauby N, Bossuyt N, ..., Barbezange C, Subissi L

The Lancet Microbe 2 (3) e105-e114 [2021-03-00; online 2021-03-00]

Category: Public Health Type: Journal article

COVID-19 drug practices risk antimicrobial resistance evolution.

Afshinnekoo E, Bhattacharya C, Burguete-García A, ..., Bhattacharyya M, MetaSUB Consortium

The Lancet Microbe - (-) - [2021-02-24; online 2021-02-24]

Type: Other

Towards pandemic preparedness beyond COVID-19

Naguib MM, Ellström P, Järhult JD, Lundkvist Å, Olsen B

The Lancet Microbe 1 (5) e185-e186 [2020-09-00; online 2020-09-00]

Type: Other